PPBT
Purple Biotech
PPBT
PPBT
16 hedge funds and large institutions have $224K invested in Purple Biotech in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
6% less capital invested
Capital invested by funds: $240K → $224K (-$15.3K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
16
Holding in Top 10
–
Calls
$263K
Puts
$7K
Top Buyers
| 1 | +$34K | |
| 2 | +$19.7K | |
| 3 | +$9.58K | |
| 4 |
Morgan Stanley
New York
|
+$2.15K |
| 5 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
+$1.9K |
Top Sellers
| 1 | -$54K | |
| 2 | -$44K | |
| 3 | -$20.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.67K |
| 5 |
FA
Fiduciary Alliance
Greenville,
South Carolina
|
-$4.49K |